Search clinical trials for: AZD6244 Erlotinib
Total 1519 results
-
University of MiamiCompleted
-
National Cancer Institute (NCI)University of Chicago; City of Hope Medical Center; University of Southern California and other collaboratorsCompleted
-
National Cancer Institute (NCI)CompletedAdenocarcinoma of the Pancreas | Recurrent Pancreatic Cancer | Stage III Pancreatic Cancer | Stage IV Pancreatic CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); GlaxoSmithKline; Merck Sharp & Dohme LLC; Nova...Completed
-
AstraZenecaCompletedHealthy VolunteersUnited States
-
National Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
National Cancer Institute (NCI)Completed
-
The Christie NHS Foundation TrustAstraZeneca; University of ManchesterCompleted
-
National Cancer Institute (NCI)NRG OncologyCompletedRecurrent Uterine Corpus Carcinoma | Endometrial Clear Cell Adenocarcinoma | Endometrial Adenocarcinoma | Endometrial Adenosquamous CarcinomaUnited States
-
AstraZenecaCompletedNon-Small Cell Lung Cancer | Advanced Solid Malignancies | Neoplasms, | Metastatic Cancer,Japan
-
National Cancer Institute (NCI)CompletedStage IV Skin Melanoma | Recurrent Melanoma | Stage III Skin MelanomaUnited States
-
National Cancer Institute (NCI)NRG OncologyCompletedPrimary Peritoneal Carcinoma | Low Grade Ovarian Serous Adenocarcinoma | Borderline Ovarian Serous Tumor | Micropapillary Serous Carcinoma | Primary Peritoneal Low Grade Serous Adenocarcinoma | Recurrent Borderline Ovarian Surface Epithelial-Stromal TumorUnited States
-
AstraZenecaCompletedMelanoma | Malignant MelanomaUnited Kingdom, Netherlands
-
National Cancer Institute (NCI)Active, not recruitingAdvanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Recurrent Neuroblastoma | Refractory Neuroblastoma | Refractory Non-Hodgkin Lymphoma | Refractory Primary Central Nervous System Neoplasm | Ann Arbor Stage III Childhood Non-Hodgkin Lymphoma and other conditionsUnited States, Puerto Rico
-
Children's Hospital Medical Center, CincinnatiAstraZenecaActive, not recruitingGlioma | Ependymoma | Meningioma | Neurofibromatosis 2 | Vestibular SchwannomaUnited States
-
National Cancer Institute (NCI)TerminatedRecurrent Adult Diffuse Large Cell LymphomaUnited States
-
Fujian Cancer HospitalUnknown
-
AstraZenecaMerck Sharp & Dohme LLCActive, not recruitingNeurofibromatosis 1 | Plexiform Neurofibroma (PN)United States, Canada, France, Italy, Germany, China, United Kingdom, Spain, Japan, Russian Federation, Australia, Poland, Brazil
-
AstraZenecaActive, not recruitingCancer | TumorUnited States, Netherlands, United Kingdom
-
AstraZenecaCompleted
-
National Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | Recurrent Adult Acute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Adult Acute Promyelocytic Leukemia (M3) | Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) | Myelodysplastic/Myeloproliferative NeoplasmsUnited States
-
AstraZenecaCompletedHealthy Volunteers Pharmacokinetic StudyUnited Kingdom
-
National Cancer Institute (NCI)Active, not recruitingLow Grade Glioma | Recurrent Visual Pathway Glioma | Refractory Visual Pathway Glioma | Recurrent Childhood Pilocytic Astrocytoma | Recurrent Neurofibromatosis Type 1 | Refractory Neurofibromatosis Type 1United States
-
Merck Sharp & Dohme LLCAstraZenecaCompletedLocally Advanced or Metastatic Solid Tumors
-
National Cancer Institute (NCI)Active, not recruitingNeurofibromatosis 1 | Neurofibroma, Plexiform | Neurofibromatosis Type 1 | NF1United States
-
National Cancer Institute (NCI)WithdrawnNeoplasms, Nerve Tissue | Peripheral Nervous System Diseases | Heredodegenerative Disorders, Nervous System | Neurofibromatosis 1
-
National Cancer Institute (NCI)CompletedRecurrent Thyroid Gland Carcinoma | Stage I Thyroid Gland Papillary Carcinoma | Stage II Thyroid Gland Papillary Carcinoma | Stage III Thyroid Gland Papillary Carcinoma | Stage IV Thyroid Gland Papillary CarcinomaUnited States, Canada
-
Guangdong Association of Clinical TrialsChia Tai Tianqing Pharmaceutical Group Co., Ltd.Unknown
-
Great Ormond Street Hospital for Children NHS Foundation...AstraZenecaCompletedNeurofibromatosis Type 1 | Optic Nerve Glioma | Plexiform NeurofibromaUnited Kingdom
-
National Cancer Institute (NCI)CompletedNeurofibromatosis Type 1 | Cutaneous Neurofibroma | Optic Nerve GliomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Melanoma | Stage IV Cutaneous Melanoma AJCC v6 and v7 | Refractory Malignant Solid Neoplasm | Unresectable Malignant Solid NeoplasmUnited States
-
National Cancer Institute (NCI)Active, not recruitingCarcinoma, Non-Small-Cell Lung | Carcinoma, Small Cell Lung | Carcinoma, ThymicUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Extrahepatic Bile Duct Cancer | Unresectable Extrahepatic Bile Duct Cancer | Liver and Intrahepatic Biliary Tract CancerUnited States
-
Duke UniversityGenentech, Inc.CompletedGlioblastoma | GliosarcomaUnited States
-
Sheffield Teaching Hospitals NHS Foundation TrustAstraZeneca; University of Sheffield; Cancer Research UK; University of Birmingham and other collaboratorsTerminatedAIDS-related Kaposi's SarcomaUnited Kingdom
-
Memorial Sloan Kettering Cancer CenterAstraZeneca; Genzyme, a Sanofi CompanyCompleted
-
National Cancer Institute (NCI)CompletedStage III Pancreatic Cancer AJCC v6 and v7 | Stage IV Pancreatic Cancer AJCC v6 and v7 | KRAS NP_004976.2:p.G12RUnited States
-
National Cancer Centre, SingaporeTerminated
-
Asan Medical CenterKorean Cancer Study Group; Boryung Pharmaceutical Co., LtdRecruitingAdvanced Solid Tumors | Metastatic Cancer | Solid TumorsKorea, Republic of
-
National Cancer Institute (NCI)CompletedColorectal NeoplasmsUnited States
-
AstraZenecaCompleted
-
Peking UniversityAstraZenecaRecruiting
-
PfizerCompletedCarcinoma, Non-Small-Cell LungUnited States
-
AstraZenecaParexelRecruitingHealthy ParticipantsUnited States, United Kingdom, Germany
-
Queen Mary University of LondonAstraZeneca; Cancer Research UKUnknownSquamous Cell Lung Cancer | Triple-Negative Breast Cancer | Non-squamous Cell Lung Cancer With KRAS Mutations | Non-squamous Cell Lung Cancer With Wild-type KRASUnited Kingdom
-
Fox Chase Cancer CenterMillennium Pharmaceuticals, Inc.TerminatedNon-small Cell Lung Cancer Metastatic | Non-small Cell Lung Cancer RecurrentUnited States
-
AstraZenecaActive, not recruitingMelanoma | Kidney Cancer | Breast Cancer | Breast Neoplasms | Lung Cancer | Colon Cancer | Colonic Cancer | Colon NeoplasmsUnited States
-
AVEO Pharmaceuticals, Inc.Biodesix, Inc.TerminatedNon-small Cell Lung CancerKorea, Republic of, United States, Australia, Taiwan, Singapore, Hong Kong, Italy
-
M.D. Anderson Cancer CenterCompletedAdvanced CancersUnited States